Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Receivables - Other (2020 - 2021)

Historic Receivables - Other for Alaunos Therapeutics (TCRT) over the last 3 years, with Q3 2021 value amounting to $1.1 million.

  • Alaunos Therapeutics' Receivables - Other changed N/A to $1.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $4.7 million for FY2020, which is N/A changed from last year.
  • Per Alaunos Therapeutics' latest filing, its Receivables - Other stood at $1.1 million for Q3 2021.
  • In the past 5 years, Alaunos Therapeutics' Receivables - Other registered a high of $7.6 million during Q2 2021, and its lowest value of $1.1 million during Q3 2021.